Dicerna Pharmaceuticals

Next-generation RNA interference (RNAi)-based therapeutics to reach previously undruggable intracellular disease targets, including cancer.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Dicerna Pharmaceuticals plus 6038 other startups.

Learn More About Dicerna Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More